Report cover image

Gene Vector Market Size, Share, By Vector Type, Therapeutic Area, Application, End-User, and Region - Trends, Analysis, and Forecast till 2035

Publisher Prophecy Market Insights
Published Dec 01, 2024
Length 177 Pages
SKU # PRMI19511717

Description

Gene vectors are essential tools in molecular biology, serving as vehicles to transfer genetic material into host cells. The target market growth is driven by the increasing demand for advanced genetic therapies particularly in treating genetic disorders, cancers and infectious diseases.

Gene Vector Market Report Highlights:
  • The gene vector market size will expand to USD 2497.4 million by 2035.
  • The market was valued at reached USD 927.2 million in 2024.
  • The market demonstrates an annual growth rate of 11.5%.
  • North America held the largest share of the market in 2024.
  • Asia Pacific is expected to be the fastest-growing market during the forecast period.
  • Under vector type, the viral vectors segment is expected to dominate the market during the forecast period.
  • By application, the gene therapy segment is leading the market.
  • On the basis of end-user, the contract development and manufacturing organizations (CDMOs) segment holds the largest gene vector market share.
Gene Vector Market Key Highlights:
  • In December 2024, The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these Centres and co-leading the other. Together, these international collaborations will receive up to £50 million each over 14 years.
  • In May 2024, SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industry, announced the upcoming launch of Lentiviral Vector (LVV) Analytical Services, a comprehensive suite of analytical testing solutions specifically designed for LVV and cell therapy programs.
Browse ∼40 market data tables and ∼38 figures through ∼177 slides and in-depth TOC on “Gene Vector Market Size, Share, By Vector Type, Therapeutic Area, Application, End-User, and Region - Trends, Analysis, and Forecast till 2035”

Gene Vector Market Competitive Landscape:

The key players in the gene vector market are Thermo Fisher Scientific Inc., Merck KGaA, SK pharmteco Inc., Lonza Group, Catalent, Cobra Biologics, Genezen Laboratories, RegenxBio, Charles River Laboratories, Fujifilm Diosynth Biotechnologies, Kaneka Eurogentec SA, uniQure NV, Alnylam Pharmaceuticals, Amgen, Bluebird Bio, and Novartis.

Segmentation:

By Vector Type:
  • Viral Vectors
  • Non-Viral Vectors
  • Exosomes
  • Others
By Therapeutic Area:
  • Neurology
  • Oncology
  • Hepatology
  • Genetic Disorders
  • Infectious Diseases
  • Others
By Application:
  • Gene Therapy
  • Cell Therapy
  • Vaccine Development
  • Others
By End User:
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Other End Users
By Region:
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

177 Pages
Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Preview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Vector Type
Market Snippet, By Therapeutic Area
Market Snippet, By Application
Market Snippet, By End-User
Market Snippet, By Region
Opportunity Map Analysis
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Vector Type Launch
Merger and Acquisitions
Impact Analysis
PEST Analysis
Porter’s Analysis
Optimization of the quality by design approach for gene therapy products
Viral vector platforms within the gene therapy landscape
Reducing the risk of vector-borne diseases
Advantages & Disadvantages
Market Segmentation, By Vector Type, Forecast Period up to 10 Years, (USD Mn)
Overview
Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Viral Vectors
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Non-Viral Vectors
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Exosomes
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Therapeutic Area, Forecast Period up to 10 Years, (USD Mn)
Overview
Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Neurology
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Oncology
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Genetic Disorders
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Infectious Diseases
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Mn)
Overview
Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Gene Therapy
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Cell Therapy
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Vaccine Development
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Mn)
Overview
Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Research Institutes
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Contract Research Organizations (CROs)
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Contract Development and Manufacturing Organizations (CDMOs)
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Other End Users
Overview
Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Mn)
Overview
Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Regional Trends
North America
Market Size and Forecast (USD Mn), By Vector Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Therapeutic Area, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
U.S.
Canada
Asia Pacific
Market Size and Forecast (USD Mn), By Vector Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Therapeutic Area, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
China
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Europe
Market Size and Forecast (USD Mn), By Vector Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Therapeutic Area, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
Germany
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
Latin America
Market Size and Forecast (USD Mn), By Vector Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Therapeutic Area, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa
Market Size and Forecast (USD Mn), By Vector Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Therapeutic Area, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
GCC
Israel
South Africa
Rest of Middle East and Africa
Competitive Landscape
Heat Map Analysis
Company Profiles
Thermo Fisher Scientific Inc.
Merck KGaA
SK pharmteco Inc.
Lonza Group
Catalent
Cobra Biologics
Genezen Laboratories
RegenxBio
Charles River Laboratories
Fujifilm Diosynth Biotechnologies
Kaneka Eurogentec SA
uniQure NV
Alnylam Pharmaceuticals
Amgen
Bluebird Bio
Novartis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us